400
Participants
Start Date
July 1, 2021
Primary Completion Date
September 8, 2021
Study Completion Date
January 31, 2023
Questionaire
"A questionnaire will be administered to all participants to evaluate exposures related to infection at the baseline (enrollement) - Baseline questionnaire. A Follow-up questionnaire to all participants will be done after 3 and 6 months.~Capillary blood collection, for diagnosis of anti-SARS-CoV-2 Antibodies by rapid test, will be done at the first interview, for all participants (cases and controls).~Collection of peripheral venous blood, for analysis of the presence and duration of anti-SARS-CoV-2 Antibodies (N and S) will be done at the first interview, and after 6 months for all participants (cases and controls)."
Universidade de Cabo Verde, Praia
University of Southern Denmark
OTHER
Institute of Hygiene and Tropical Medicine, NOVA University, Lisbon, Portugal
UNKNOWN
National Institute of Public Health of Cape Verde, Praia, Cape Verde
UNKNOWN
Centro de Investigacao em Saude de Manhica
OTHER
European and Developing Countries Clinical Trials Partnership (EDCTP)
OTHER_GOV
Bandim Health Project, Bissau, Guinea-Bissau
UNKNOWN
Universidade de Cabo Verde
OTHER